EUROPEAN CALCIFIED TISSUE SOCIETY
50th Annual Meeting of the European Calcified Tissue Society15-18 April Liverpool
N. Poster
Poster title
Applicant name
Status
 |
|
|
|
| P-059 | Distinguishing prostate cancer grades using X-ray and spectroscopic analysis of calcifications | Sarah Gosling |  Received |
 |
|||
| P-067 | Influence of vitamin D and vitamin K metabolite concentrations on different bone mineral densities in postmenopausal women | Sieglinde Zelzer | Received |
|
|||
| P-085 | Alterations in bone intrinsic and compositional properties at the cement lines in interstitial bone of postmenopausal women diagnosed with long-term Type-1 Diabetes | Sonja Gamsjaeger | Received |
|
|||
| P-095 | Psychostimulant Prescription, Prevalence, and Recovery Following Distal Radius Fractures in a Pediatric Population | Thomas Carroll | Received |
|
|||
| P-103 | Humanin treatment prevents bone growth impairment caused by venetoclax in cultured rat metatarsal bones | Lilly Velentza | Received |
|
|||
| P-111 | MechanoChip A novel mechanobiology-based drug screening in vitro platform for bone metastases | Cornelia Bratengeier | Received |
|
|||
| P-120 | Medical management is a viable alternative in tumour induced osteomalacia with failed tumour localisation | Abhranil Dhar | Received |
|
|||
| P-121 | Simultaneous inhibition of Myostatin and Activin A effectively reduces osteoclast-mediated bone loss in a xenograft mouse model of breast cancer metastasis | Corinna Wehmeyer | Received |
|
|||
| P-154 | Epigenome-wide DNA methylation in octogenarians: BMD and fracture outcomes | Fiona E McGuigan | Received |
|
|||
| P-157 | A new node of transcription factors regulating the equilibrium between osteoblastogenesis and adipogenesis. | Ana Alonso-Pérez | Received |
|
|||
| P-163 | Calcinosis cutis independent risk factor for all-cause mortality in autoimmune rheumatic diseases | Cristina Nita | Received |
|
|||
| P-170 | Reactive Arthritis following COVID-19 infection: Case Series | Maria Lolou | Received |
|
|||
| P-173 | The effect of intra-articular injection of hyaluronic acid for mild to moderate knee osteoarthritis in rheumatoid arthritis patients | Dimitrios Giotis | Received |
|
|||
| P-180 | Tapering Denosumab to discontinuation a new strategy to avoid the rebound phenomenon? Nine case reports | Tove Tveitan Borgen | Received |
|
|||
| P-218 | Preventing abnormal bone growth: a new therapy for heterotopic ossification | Ana Alonso-Pérez | Received |
|
|||
| P-225 | Hordenine inhibits bone resorption via regulation of calcium homeostasis | JIHEE KIM | Received |
|
|||
| P-226 | Transcriptomic differences underlying the Activin-A induced large osteoclast formation | Ton Schoenmaker | Received |
|
|||
| P-230 | The effect of sclerostin and monoclonal sclerostin antibody Romosozumab on osteogenesis and osteoclastogenesis mediated by periodontal ligament fibroblasts | Teun de Vries | Received |
|
|||
| P-238 | Bone mineral density, trabecular bone score (TBS) and body-fat analysis in type 1 diabetes by DXA and co-relation with biochemical parameters; case-control study from India | Shinjan Patra | Received |
|
|||
| P-257 | A potential role of hepcidin deficiency in the occurrence of iron related osteoporosis. Genetic and secondary iron overload mouse models induce differences in with. | Franois ROBIN | Received |
|
|||
| P-260 | Sustained Hypophosphatemia after Denosumab in a Chronic Kidney Disease patient on Hemodialysis | Ahmed A.S. Almodares | Received |
|
|||
| P-264 | Dosing of intermittent iv. Zoledronic acid based on bone turnover marker assessment preserves bone mineral density over eight years | Erik Fink Eriksen | Received |
|
|||
| P-274 | Eldecalcitol prevented OVX-induced osteoporosis through inhibiting BMSCs senescence by regulating the SIRT1-Nrf2 signal | hongrui liu | Received |
|
|||
| P-292 | Neurogenic Heterotopic Ossification Deconstruction: a New in vitro Model Reveals Nerve System-Derived Factors Modulate Osteoblast and Adipocyte Metabolism | María Guillán-Fresco | Received |
|
|||
| P-314 | Pharmacokinetics and Pharmacodynamics of Garetosmab in Patients with Fibrodysplasia Ossificans Progressiva | de Ruiter Ruben | Received |
|
|||
| P-315 | Characterisation of New Heterotopic Ossification Lesions in Patients with Fibrodysplasia Ossificans Progressiva by PET/CT vs CT Only | Gonzalez Trotter Dinko | Received |
|
|||
| P-316 | Treatment with the PI3Kalpha inhibitor BYL719 unveils a differential regulation of AP-1 by Activin in Fibrodysplasia ossificans progressiva | Gonzalo Sanchez-Duffhues | Received |
|
|||
| P-322 | Osteoporosis and knock knee in a tall young man: A rare case of aromatase deficiency | Pankaj Singhania | Received |
|
|||
| P-326 | Generation of the first Progressive Osseous Heteroplasia in vitro model from a patient with a GNAS de novo mutation | María Piñeiro-Ramil | Received |
|
|||
50th Annual Meeting of the European Calcified Tissue Society
15-18 April Liverpool
Search and consult posters online
in an exclusive section
for each poster
in an exclusive section
for each poster
ACTIVE FROM 15/04/2023 TO 15/04/2024
Poster
Gallery
Gallery
Upload
Poster
Poster
Featured Poster
Vote poster
Poster Discussion
Forum
Forum
|
Digital Object Identifier. Official code used to identify documents published on internet; similar to ISBN for books. You may use this code to reference your poster in future scientific publications or CVs. It can be found from anywhere in the world. To find the poster page, log onto www.medra.org and enter the DOI, or enter in your internet browser https://dx.doi.org/ followed by the DOI string asigned to your congress.
|
|
||
|
||||
Poster submission deadline 30/03/2023
|
|
